Plantar Fasciitis Treatment Market Report 2026
Global Outlook – By Type (Medication Therapy, Orthotics, Shockwave Therapy, Surgery, Other Types), By Diagnosis (Medical History, Physical Examination, X-Rays, Radiography, Other Diagnosis), By End User (Hospitals, Clinics, Other End Users) - Market Size, Trends, Strategies, and Forecast to 2030
Plantar Fasciitis Treatment Market Overview
• Plantar Fasciitis Treatment market size has reached to $2.07 billion in 2025 • Expected to grow to $5.69 billion in 2030 at a compound annual growth rate (CAGR) of 22.2% • Growth Driver: Rising Diabetes Is Anticipated To Fuel Plantar Fasciitis Treatment Market • Market Trend: Adoption of Wearable Long-Duration Ultrasound Devices in Plantar Fasciitis Treatment • North America was the largest region in 2025.What Is Covered Under Plantar Fasciitis Treatment Market?
Plantar fasciitis treatment refers to the medical care or preventive measures given to a patient to evaluate the incidence and frequency of a degenerative condition of the thick band of tissue at the base of the foot. Physical therapy is an important component of plantar fasciitis treatment. The major types of plantar fasciitis treatment are medication therapy, orthotics, shockwave therapy, surgery, and others. Medication therapy refers to the treatment of any illness or disease through the use of prescription or non-prescription medicines, over-the-counter medications, and herbal medications. It can be diagnosed by medical history, physical examination, X-rays, radiography, and others, and is used by hospitals, clinics, and others.
What Is The Plantar Fasciitis Treatment Market Size and Share 2026?
The plantar fasciitis treatment market size has grown exponentially in recent years. It will grow from $2.07 billion in 2025 to $2.55 billion in 2026 at a compound annual growth rate (CAGR) of 23.1%. The growth in the historic period can be attributed to increasing prevalence of foot and heel pain disorders, rising incidence of obesity-related foot conditions, growing participation in sports activities, improved availability of physical therapy services, expansion of orthopedic care facilities.What Is The Plantar Fasciitis Treatment Market Growth Forecast?
The plantar fasciitis treatment market size is expected to see exponential growth in the next few years. It will grow to $5.69 billion in 2030 at a compound annual growth rate (CAGR) of 22.2%. The growth in the forecast period can be attributed to increasing adoption of advanced diagnostic imaging, rising demand for personalized orthotic products, expansion of outpatient orthopedic treatments, growing focus on preventive musculoskeletal care, increasing integration of physical therapy in treatment protocols. Major trends in the forecast period include increasing adoption of non-invasive treatment options, rising use of shockwave and physical therapy modalities, growing demand for custom orthotic solutions, expansion of multidisciplinary foot care approaches, enhanced focus on early diagnosis and conservative care.
Global Plantar Fasciitis Treatment Market Segmentation
1) By Type: Medication Therapy, Orthotics, Shockwave Therapy, Surgery, Other Types 2) By Diagnosis: Medical History, Physical Examination, X-Rays, Radiography, Other Diagnosis 3) By End User: Hospitals, Clinics, Other End Users Subsegments: 1) By Medication Therapy: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Pain Relievers, Topical Treatments 2) By Orthotics: Custom Orthotic Inserts, Over-The-Counter Insoles, Night Splints, Heel Cups 3) By Shockwave Therapy: Radial Shockwave Therapy, Focused Shockwave Therapy 4) By Surgery: Plantar Fascia Release, Gastrocnemius Recession, Other Surgical Procedures 5) By Other Types: Physical Therapy, Massage Therapy, Stretching And Strengthening Exercises, Alternative TherapiesWhat Is The Driver Of The Plantar Fasciitis Treatment Market?
The rising diabetes is expected to propel the growth of the plantar fasciitis treatment market. Diabetes is a chronic medical condition characterized by elevated blood sugar levels resulting from insufficient insulin production or ineffective use of insulin by the body. The use of plantar fasciitis treatment in diabetes aims to alleviate foot pain and discomfort associated with inflammation of the plantar fascia, promoting better mobility and reducing the risk of complications. For instance, in 2023, according to a report published by the Health Data Institute, approximately 529 million people worldwide are living with diabetes. Projections suggest that if current trends continue, this figure could escalate to 1.3 billion by 2050. Therefore, the rising diabetes is driving the plantar fasciitis treatment industry.Key Players In The Global Plantar Fasciitis Treatment Market
Major companies operating in the plantar fasciitis treatment market are Bayer AG, Superfeet Worldwide LLC, Bauerfeind AG, Ottobock SE & Co. KGaA, Sanofi SA, Eli Lilly and Company, GlaxoSmithKline plc, Pfizer Inc., Bristol-Myers Squibb Company, Scholl’s Wellness Co., Hanger Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., Smith & Nephew plc, Arthrex Inc., DJO Global Co., Medline Industries Inc., Bird & Cronin Inc., Aetrex Worldwide Inc., Zimmer Biomet Holdings Inc., Stryker Corporation, Breg Inc., TheraBand LLC, Foot Levelers Inc.
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.
This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Explore how leading companies compare across key metrics in our report Get Report
Global Plantar Fasciitis Treatment Market Trends and Insights
Major companies are operating in the plantar fasciitis treatment market, focusing on developing technological advancements such as wearable long-duration ultrasound devices for at-home soft-tissue therapy to enhance healing, reduce pain, and minimize reliance on invasive procedures. A wearable long-duration ultrasound device delivers continuous low-intensity ultrasonic energy directly to soft tissue, stimulating blood flow, oxygenation, and cellular repair providing a non-invasive alternative to traditional orthotics, pain medications, or corticosteroid injections. For instance, in June 2025, ZetrOZ Systems, a US-based medical device manufacturer, launched the sam 2.0, an advanced wearable ultrasound device for plantar fasciitis treatment. The product delivers multi-hour, low-intensity ultrasound therapy that promotes collagen deposition, accelerates soft-tissue repair, reduces inflammation, and can be self-administered at home, offering patients a convenient, drug-free, non-surgical treatment option.What Are Latest Mergers And Acquisitions In The Plantar Fasciitis Treatment Market?
In September 2024, Bansk Group, a US-based investment firm, acquired Foundation Wellness for an undisclosed amount. Through this acquisition, Bansk Group aims to strengthen its plantar fasciitis treatment portfolio by integrating Foundation Wellness’s specialty orthotics, insoles, and foot-care solutions, expanding its offerings for foot pain relief. Foundation Wellness is a US-based company that provides orthotics, footbeds or insoles, orthopedic braces, and wellness-focused foot-care products specifically designed to address plantar fasciitis and other foot-related conditions.
Regional Outlook
North America was the largest region in the plantar fasciitis treatment market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.Need data for a specific geography? Request Regional Data
What Defines the Plantar Fasciitis Treatment Market?
The plantar fasciitis treatment market includes revenues earned by entities by provide extracorporeal shock wave therapy (ESWT), intracorporeal pneumatic shock wave therapy (IPST), inflammation-related pain drugs, and non-operative treatments. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.
This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
Access full TAM calculations and growth projections in our report Get Report
What Key Data and Analysis Are Included in the Plantar Fasciitis Treatment Market Report 2026?
The plantar fasciitis treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the plantar fasciitis treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Plantar Fasciitis Treatment Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $2.55 billion |
| Revenue Forecast In 2030 | $5.69 billion |
| Growth Rate | CAGR of 22.2% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Type, Diagnosis, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain |
| Key Companies Profiled | Bayer AG, Superfeet Worldwide LLC, Bauerfeind AG, Ottobock SE & Co. KGaA, Sanofi SA, Eli Lilly and Company, GlaxoSmithKline plc, Pfizer Inc., Bristol-Myers Squibb Company, Scholl’s Wellness Co., Hanger Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., Smith & Nephew plc, Arthrex Inc., DJO Global Co., Medline Industries Inc., Bird & Cronin Inc., Aetrex Worldwide Inc., Zimmer Biomet Holdings Inc., Stryker Corporation, Breg Inc., TheraBand LLC, Foot Levelers Inc. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |